DARPA starts blood manufacturing project

06/12/2007 | United Press International

The Defense Advanced Research Projects Agency hopes to grow Type O negative blood outside of the body to help limit combat deaths, many of which occur due to blood loss. The program seeks to develop an automated progenitor cell-based culture system to create normal red blood cells. The group also will look for ways to extend the shelf life of blood donations.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY